p53 down-regulation: A new molecular mechanism involved in ischaemic preconditioning

FEBS Letters

Volumn 555, Issue 2, 2003, Pages 302-306

  Mocanu, Mihaela M ^a   Yellon, Derek M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ischemic preconditioning; Mdm2 phosphorylation; Myocardial ischemia; p53 downregulation; Phosphatidylinositol 3 kinase Akt pathway

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; DOWN REGULATION; DRUG EFFECT; HEART INFARCTION PREVENTION; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

MURINAE;

EID: 0344009488     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)01260-2     Document Type: Article

References (22)

1. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. Circulation. 97:1998;1848-1867.
2. Zhao Z.Q., Vinten-Johansen J. Cardiovasc. Res. 55:2002;438-455.
3. Alarcon-Vargas D., Ronai Z. Carcinogenesis. 23:2002;541-547.
4. Gottlieb T.M., Leal J.F.M., Seger R., Taya Y., Oren M. Oncogene. 21:2002;1299-1303.
5. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., Gotoh Y. J. Biol. Chem. 24:2002;21843-21850.
6. Vousden K.H. Biochim. Biophys. Acta. 1602:2002;47-59.
7. Bargonetti J., Manfredi J. Curr. Opin. Oncol. 14:2002;86-91.
8. Vousden K.H., Lu X. Nat. Rev. Cancer. 2:2002;594-604.
9. Regula K.M., Kirshenbaum L.A. J. Mol. Cell. Cardiol. 33:2001;1435-1445.
10. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. Mol. Cell. 11:2003;577-590.
11. Zhao Z.Q., Velez D.A., Wang N.P., Hewan-Lowe K.O., Nakamura M., Guyton R.A., Vinten-Johansen J. Apoptosis. 4:2001;279-290.
12. Maulik N., Sasaki H., Addya S., Das D.K. FEBS Lett. 485:2000;7-12.
13. Culmsee C., Zhu X., Yu Q.S., Chan S.L., Camandola S., Guo Z., Greig N.H., Mattson M.P. J. Neurochem. 1:2001;220-228.
14. Tomasevic G., Shamloo M., Israeli D., Wieloch T. Mol. Brain Res. 70:1999;304-313.
15. Haupt Y., Robles A.I., Prives C., Rotter V. Oncogene. 21:2002;8223-8231.
16. Ashcroft M., Ludwig R.L., Woods D.B., Copeland T.D., Weber H.O., MacRae E.J., Vousden K.H. Oncogene. 21:2002;1955-1962.
17. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. Science. 285:1999;1733-1737.
18. Mocanu M.M., Bell R.M., Yellon D.Y. J. Mol. Cell. Cardiol. 34:2002;661-668.
19. Tong H., Chen W., Steenbergen C., Murphy E. Circ. Res. 87:2000;309-315.
20. Baines C.P., Wang L., Cohen M.V., Downey J.M. Basic Res. Cardiol. 94:1999;188-198.
21. Mayo L., Donner D.B. Proc. Natl. Acad. Sci. USA. 98:2001;11598-11603.
22. Ashcroft M., Vousden K.H. Oncogene. 18:1999;7637-7643.